Innovating Works

CHALICE MEDICAL LTD

Desconocido
EURO SHOCK: Testing the value of a novel strategic approach and its cost efficacy to improve the poor outcomes i... CHALICE MEDICAL LIMITED participó en un H2020: H2020-SC1-2016-2017 Heart attacks are common and can leave survivors suffering cardiogenic shock (CGS), with its extremely high risk of early death (42% versus...
2017-12-05 - 2022-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.